Curaleaf Holdings, Inc. (CURLF): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$63.44M

Year ended 2025-12-31

$65.56M

Trailing 12 months to 2026-06-30

-22.2%

3-year compound annual growth

2021-12-31 Capital Expenditures (USD) 2025-12-31

Period ended	Capital Expenditures	Change YoY	Source filing
2025-12-31	$63.44M	-31.4%	2026-02-27, From 2025-01-01
2024-12-31	$92.44M	+41.2%	2026-02-27, From 2024-01-01
2023-12-31	$65.45M	-51.4%	2025-03-04, From 2023-01-01
2022-12-31	$134.64M	n/c	2024-03-07, From 2022-01-01
2021-12-31	$171.96M	n/a	2023-05-03, From 2021-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Capital Expenditures	Change YoY
Curaleaf Holdings, Inc. (CURLF)	2025-12-31	$63.44M	-31.4%
Trulieve Cannabis Corp. (TRLV)	2025-12-31	$44.19M	-64.0%
USANA Health Sciences Inc (USNA)	2026-01-03	$13.82M	+37.2%
Tilray Brands, Inc. (TLRY)	2025-05-31	$32.92M	+12.5%
Cresco Labs Inc. (CRLBF)	2025-12-31	$35.14M	+80.3%
Ascend Wellness Holdings, Inc. (AAWH)	2025-12-31	$26.01M	+15.4%
Jushi Holdings Inc. (JUSH)	2025-12-31	$16.09M	+241.8%
biote Corp. (BTMD)	2025-12-31	$5.01M	-22.0%
Glass House Brands Inc. (GLAS)	2025-12-31	$27.18M	+164.0%

Compare CURLF, TRLV, USNA, TLRY side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗